Back
Renalytix PLC Vs. Dyne Therapeutics Industry Stock Comparison
Sell
27
RNLX
Renalytix PLC
Last Price:
0.26
Seasonality Move:
-13.41%
Sell
31
DYN
Dyne Therapeutics
Last Price:
33.84
Seasonality Move:
5.51%
Sell
27
Renalytix PLC (RNLX)
is a Sell
Is Renalytix PLC a Buy, Sell or Hold?
- The current Renalytix PLC [RNLX] share price is $0.26. The Score for RNLX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- RNLX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
Dyne Therapeutics (DYN)
is a Sell
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $33.83. The Score for DYN is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- DYN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RNLX Stock Price Chart
What is Renalytix PLC's stock price today?
-
The Renalytix PLC share price today is $0.26
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNLX is experiencing selling pressure, which indicates risk of future bearish movement.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $33.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DYN is experiencing selling pressure, which indicates risk of future bearish movement.
RNLX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 40.92 | Sell |
Chaikin Money Flow: | -143084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.27 - 0.31) | Sell |
Bollinger Bands (100): | (0.28 - 0.48) | Sell |
DYN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.64 | Sell |
Relative Strength Index (14 RSI): | 40.26 | Sell |
Chaikin Money Flow: | -399891 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.67 - 41.65) | Sell |
Bollinger Bands (100): | (30.76 - 42.62) | Sell |
RNLX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.28 | Sell |
20-day SMA: | 0.28 | Sell |
50-day SMA: | 0.33 | Sell |
200-day SMA: | 0.52 | Sell |
8-day EMA: | 0.27 | Sell |
20-day EMA: | 0.29 | Sell |
50-day EMA: | 0.32 | Sell |
200-day EMA: | 0.67 | Sell |
DYN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 34.84 | Sell |
20-day SMA: | 34.54 | Sell |
50-day SMA: | 40.17 | Sell |
200-day SMA: | 29.41 | Buy |
8-day EMA: | 34.53 | Sell |
20-day EMA: | 35.81 | Sell |
50-day EMA: | 37.51 | Sell |
200-day EMA: | 30.51 | Buy |
Renalytix PLC Earnings Growth & RNLX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.17 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.82 per share, and a decrease next year of $0.01 per share.
Renalytix PLC Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dyne Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |